Reval, a global leader in financial risk management solutions and services, today announced the appointment of Steve Rosenberg to its Board of Directors. Rosenberg is SVP of Phase Forward, one of the leading providers of data management solutions for clinical trials and drug safety. At Phase Forward, Rosenberg oversees product development, product management, the North American services organization and the companyâs worldwide production hosting operation. âSteve Rosenberg is a welcome addition to Revalâs Board of Directors and we were fortunate to find someone with experience in hosting and supporting complex applications over the Web,â said Jiro Okochi, Revalâs CEO and Co-founder. âWe look forward to working with Steve as we further develop Revalâs award-winning SaaS hedge accounting solution,â continued Okochi.
Rosenberg has over 27 years experience in the software industry. Prior to Phase Forward, Rosenberg served as the Senior Vice President of Development and Client Services at W3 Health, where he led the development and implementation of the companyâs flagship healthcare analytics ASP environment, and participated in venture capital activities and sales campaigns. Rosenbergâs extensive career has included prior leadership roles at McKessonHBOC (formerly HPR, Inc.), Sales Technologies (a division of Dun & Bradstreet) and TRINZIC (formerly AICorp).
In addition to his professional work, Rosenberg currently serves as Chairman of the Board of Trustees for St. Annâs Home, a school and residential facility for disturbed and abused children.